questionText: To ask the Secretary of State for Health and Social Care, with reference to the Government response to the Women and Equalities Committee report on Tackling HIV transmission, HC 1663, what the basis is for the estimate that Cabotegravir injectable PrEP wi
answerText: Cabotegravir pre-exposure prophylaxis (PrEP) was recommended by the National Institute for Health and Care Excellence (NICE) as a clinically and cost-effective use for people who cannot have oral PrEP on 5 November 2025.NICE estimated that up to 1,000 peo...
heading: HIV Infection: Drugs